Global Polyp Biopsy Market, By Type (Colonoscopy, Colposcopy-Directed Biopsy, Esophagogastroduodenoscopy, Laryngoscopy), Distribution Channel (Online Sales Channels, Retail Pharmacies), End User (Hospitals & Clinics, Diagnostic Centres, Academic & Research Organizations), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028
Market Analysis and Insights : Global Polyp Biopsy Market
The polyp biopsy market is expected to witness market growth at a rate of 5.88% in the forecast period of 2021 to 2028 and is expected to reach USD 1,826.72 million by 2028. Data Bridge Market Research report on polyp biopsy market provides analysis and insights regarding the various factors expected to be prevalent throughout the forecast period while providing their impacts on the market’s growth. The rise in the prevalence of polyps is escalating the growth of polyp biopsy market.
Polyps refer to abnormal tissue growths that most often look similar to flat, small bumps or tiny mushroom type stalks. Most of these are small and less than half an inch wide. Most of these polyps are small and less than half an inch wide which are benign or non-cancerous. The abnormal cell growth result in polyps, thus they could turn into malignant or cancerous. Doctor assist in determining the growth is a polyp by performing a biopsy. A small sample of tissue is taken and tested to see the presence of cancerous cells.
The increase in the cases of polyps and increasing incidences of colorectal cancer act as the major factors driving the growth of polyp biopsy market. The high usage of the biopsy to diagnose cancer and help distinguish healthy cells or calluses from tumorous cells and increasing demand for minimally invasive medical procedures accelerate the polyp biopsy market growth. The increasing adoption of the procedure by interventional radiologists and the diagnostic department to determine diseases for a healthcare institution such as medical clinics and diagnostic centers among others and rise in awareness regarding early diagnosis and its benefits among people further influence the polyp biopsy market. Additionally, growing population, unhealthy lifestyle, rising awareness about various diseases, surge in healthcare expenditure and growing number of cancer awareness campaigns positively affect the polyp biopsy market. Furthermore, technological advancement extends profitable opportunity to the polyp biopsy market players in the forecast period of 2021 to 2028.
On the other hand, the issues with the uncertain regulatory norms and policies are expected to obstruct the polyp biopsy market growth. The rise in the concerns regarding the biopsy-related risk of infections is projected to challenge the polyp biopsy market in the forecast period of 2021-2028.
This polyp biopsy market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on polyp biopsy market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Polyp Biopsy Market Scope and Market Size
The polyp biopsy market is segmented on the basis of type, distribution channel and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of type, the polyp biopsy market is segmented into colonoscopy, colposcopy-directed biopsy, esophagogastroduodenoscopy and laryngoscopy.
- On the basis of distribution channel, the polyp biopsy market is segmented into online sales channels and retail pharmacies.
- On the basis of end user, the polyp biopsy market is segmented into hospitals & clinics, diagnostic centres and academic & research organizations.
Global Polyp Biopsy Market Country Level Analysis
The polyp biopsy market is analyzed and market size insights and trends are provided by country, type, distribution channel and end user as referenced above.
The countries covered in the global polyp biopsy market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the polyp biopsy market because of the presence of developed economies such as the U.S. and Canada, high expenditure on the health care and extensive use of medications in the region. Asia-Pacific is expected to witness significant growth during the forecast period of 2021 to 2028 due to the growth of healthcare sector, increasing government initiatives and availability of technologically enhanced smart biopsy devices in the region.
The country section of the polyp biopsy market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The polyp biopsy market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for polyp biopsy market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on polyp biopsy market. The data is available for historic period 2011-2019.
Competitive Landscape and Polyp Biopsy Market Share Analysis
The polyp biopsy market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to polyp biopsy market.
The major players covered in the polyp biopsy market report are Cardinal Health, Tous droits réservés Angiotech, BD, Hologic, Inc., INRAD, Inc., Devicor Medical Products, Inc., Olympus Corporation, DTR Medical Ltd, Cigna, Dr Lal PathLabs, STERIS, Mayo Foundation, Boston Scientific Corporation among other domestic and global players. Market share data is available for global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
SKU-